Summary & Overview
Other Musculoskeletal System and Connective Tissue O.R. Procedures with MCC: Inpatient Reimbursement Overview
DRG 515 covers complex operative procedures on the musculoskeletal system and connective tissue when a Major Complication or Comorbidity is present, encompassing high-resource joint and reconstructive surgeries with significant perioperative issues. This Diagnosis-Related Group matters for inpatient reimbursement because Major Complication or Comorbidity presence drives higher payment relative to less complex musculoskeletal operating room procedures due to increased resource use and care intensity.
DRG 515 Overview
DRG 515 covers complex inpatient operating room procedures involving the musculoskeletal system and connective tissue when a Major Complication or Comorbidity is present, such as extensive reconstructive surgery, major joint operations with significant perioperative issues, or multi-tissue repairs. This Diagnosis-Related Group groups high-resource surgical cases that incur greater inpatient costs due to the procedure complexity and the presence of a Major Complication or Comorbidity. It matters for Medicare payment because cases assigned here typically receive higher reimbursement to account for increased resource use, longer lengths of stay, and more intensive postoperative care. Accurate coding and documentation of procedures and Major Complication or Comorbidity status determine assignment to this Diagnosis-Related Group and therefore affect inpatient payment.
Clinical Trials
- Trials of perioperative management strategies for complex musculoskeletal or connective tissue operations with major complications: randomized or pragmatic studies evaluate protocols for preoperative optimization, intraoperative blood loss control, and intensive postoperative monitoring in patients undergoing high-risk orthopedic or soft-tissue reconstructive procedures who experience or are at high risk for major complications (eg, sepsis, multi‑system organ dysfunction). These studies focus on acute interventions and care bundles to reduce short-term mortality, length of stay, and complication-related readmissions, directly informing inpatient resource utilization and payer metrics for DRG 515.
- Comparative effectiveness studies of surgical technique or timing in patients requiring emergent or complex operative repair for musculoskeletal/connective tissue conditions complicated by comorbidities: prospective cohort or randomized studies compare alternative operative approaches (eg, staged versus single-stage reconstruction, minimally invasive versus open approaches) or timing strategies in older adults or medically complex patients with infections, fractures with soft-tissue compromise, or failed prior repairs. Results address clinician decisions that affect perioperative complication rates and use of intensive services, helping hospitals and payers evaluate cost-effectiveness and appropriate DRG assignment for high-acuity cases.
- Post-discharge functional outcomes and utilization research in survivors of major musculoskeletal O.R. procedures with complications: observational studies and registries track long-term functional recovery, rehabilitation needs, subsequent procedures, and post-acute care utilization among patients discharged after complicated operative courses. This research identifies predictors of prolonged rehabilitation, durable disability, and repeat hospital use, informing discharge planning, coverage decisions for post-acute services, and value-based payment models tied to DRG 515 outcomes.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.